Innovate GBM

Innovate GBM

Real-world breakthroughs, biotech partnerships, and investments fueling GBM innovation.

BioLineRx and Hemispherian Partner to Develop GLIX1, a First-in-Class Oral Glioblastoma Therapy

Innovate GBM’s 2025 Investment Playbook Year to Date Review

Glioblastoma Funding Rises as Nonprofits Drive Interest and Pharma Returns to the Table

NeOnc Finalizes $50M Quazar Deal as NuroMENA Joins ADGM

Innovate GBM Rings the NASDAQ Closing Bell

Alpheus Medical Raises $52M to Advance Glioblastoma Therapy

Jazz Pharmaceuticals Completes Acquisition of Chimerix

OSR Holdings, Inc - $80M Equity Line of Credit with White Lion GBM Innovation Fund

NeOnc Technologies - Successful Direct Listing on NASDAQ

Modifi Biosciences Acquired by Merck

MimiVax Raises $5.8M for Cancer Drug Trial

Kazia Therapeutics - $15M Purchase Agreement

Transcode Therapeutics - $1M Common Stock Purchase Agreement

Ocean Biomedical - $75M Common Stock Purchase Agreement

Innovate GBM

Innovate GBM is not about business. It is about saving lives, providing hope, and changing the future for the better.

Navigation

Newsletter

Sign up for our newsletter to receive latest updates on Innovate GBM